Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

The Lancet ◽  
2008 ◽  
Vol 372 (9634) ◽  
pp. 207-215 ◽  
Author(s):  
Rachelle S Doody ◽  
Svetlana I Gavrilova ◽  
Mary Sano ◽  
Ronald G Thomas ◽  
Paul S Aisen ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Activities Of Daily Living ◽  
Daily Living ◽  
Controlled Study ◽  
Double Blind ◽  
Global Function ◽  
Double Blind Placebo

scholarly journals Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

2012 ◽  
Vol 4 (5) ◽  
pp. 43 ◽  
Author(s):  
John M Ringman ◽  
Sally A Frautschy ◽  
Edmond Teng ◽  
Aynun N Begum ◽  
Jenny Bardens ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo

DHEA treatment of Alzheimer's disease: A randomized, double-blind, placebo-controlled study

Neurology ◽  
2003 ◽  
Vol 60 (7) ◽  
pp. 1071-1076 ◽  
Author(s):  
O.M. Wolkowitz ◽  
J.H. Kramer ◽  
V.I. Reus ◽  
M.M. Costa ◽  
K. Yaffe ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Controlled Study ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Dhea Treatment
Sign in / Sign up

Export Citation Format

Share Document